Guo Shengfu, Wang Zidong, Kang Xiaokui, Xin Wenqiang, Li Xin
Department of Neurosurgery, Liaocheng People's Hospital, Liaocheng, China.
Department of Neurology, University Medical Center Goettingen, Göttingen, Germany.
Front Neurol. 2021 Mar 23;12:614382. doi: 10.3389/fneur.2021.614382. eCollection 2021.
Although microscopic (MTSS) and endoscopic transsphenoidal surgery (ETSS) are both effective approaches for treating non-functioning pituitary adenomas (NFPA) and functioning pituitary adenomas (FPA), the consensus remains unidentified on whether there are differences in the risk of postoperative complications between the two surgical approaches. A meta-analysis of the study of MTSS vs. ETSS for NFPA and FPA was conducted by searching the electronic databases of PubMed, Cochrane Library, and EMBASE, from the date of establishment of electronic databases to September 2020 based on the PRISMA guidelines. In this study, a total of 16 studies were selected, hailing from Belgium, the USA, India, Finland, France, Korea, Spain, China, and Canada. We enrolled 1003 patients in the ETSS and 992 patients in the MTSS group. In patients with NFPA, the ETSS group was related to a higher incidence of post-operative gross-total resection (GTR). (OR = 1.655, 95% CI 1.131-2.421, = 0.010). In participants with FPA, the results illustrated that the ETSS group had higher rates of visual improvement (OR = 2.461, 95% CI 1.109-5.459) and gross-total resection (OR = 2.033, 95% CI 1.335-3.096), as well as lower meningitis rates (OR = 0.195, 95% CI 0.041-1.923). In participants with acromegaly, no significant difference was shown in the postoperative complications. Based on current evidence, participants with NFPA treated by endoscopy were related to higher rates of GTR; patients with FPA treated by ETSS were related to higher rates of visual improvement and GTR, as well as a lower rates of meningitis.
尽管显微镜下经蝶窦手术(MTSS)和内镜经蝶窦手术(ETSS)都是治疗无功能性垂体腺瘤(NFPA)和功能性垂体腺瘤(FPA)的有效方法,但对于这两种手术方法术后并发症风险是否存在差异,目前仍未达成共识。根据PRISMA指南,通过检索PubMed、Cochrane图书馆和EMBASE的电子数据库,对从电子数据库建立之日至2020年9月期间关于MTSS与ETSS治疗NFPA和FPA的研究进行了荟萃分析。在本研究中,共选取了16项研究,这些研究来自比利时、美国、印度、芬兰、法国、韩国、西班牙、中国和加拿大。我们将1003例患者纳入ETSS组,992例患者纳入MTSS组。在NFPA患者中,ETSS组术后全切除(GTR)发生率较高(OR = 1.655,95%CI 1.131 - 2.421,P = 0.010)。在FPA患者中,结果表明ETSS组视力改善率(OR = 2.461,95%CI 1.109 - 5.459)和全切除率(OR = 2.033,95%CI 1.335 - 3.096)较高,脑膜炎发生率较低(OR = 0.195,95%CI 0.041 - 1.923)。在肢端肥大症患者中,术后并发症无显著差异。基于目前的证据,内镜治疗的NFPA患者GTR率较高;ETSS治疗的FPA患者视力改善率和GTR率较高,脑膜炎发生率较低。